A paradigm shift towards production of sustainable bioenergy and advanced products from Cannabis/hemp biomass in Canada
Abstract The global cannabis (Cannabis sativa) market was 17.7 billion in 2019 and is expected to reach up to 40.6…
Abstract The global cannabis (Cannabis sativa) market was 17.7 billion in 2019 and is expected to reach up to 40.6…
Abstract Cannabidiol (CBD), a major non-psychotropic component of cannabis, is receiving growing attention as a potential anticancer agent. CBD suppresses…
Abstract PURPOSE: The liberalization of cannabis policies has the potential to affect the use of other substances and the harms…
Abstract The antineoplastic effects of cannabis have been known since 1975. Since the identification of the components of the endogenous…
Abstract Background: Δ9-tetrahydrocannabinol (THC) is the main psychoactive component and one of the most important medicinal compounds in cannabis. Whether…
Abstract Gender differences in psychiatric disorders and drug use are well known. Cannabis is the most widely used illegal drug…
Abstract Simple Summary: Neurodegenerative diseases represent an important cause of morbidity and mortality worldwide. Existing therapeutic options are limited and…
Abstract Aim: We undertook this systematic review to determine the efficacy and safety of cannabis-based medicine as a treatment for…
Abstract Cancer patients often use cannabinoids for alleviating symptoms induced by cancer pathogenesis and cancer treatment. This use of cannabinoids…
Abstract Many people worldwide use plant preparations for medicinal purposes. Even in industrialized regions, such as Europe, where conventional therapies…